Index RUT
P/E -
EPS (ttm) -5.57
Insider Own 32.72%
Shs Outstand 29.65M
Perf Week 6.97%
Market Cap 640.27M
Forward P/E -
EPS next Y -0.94
Insider Trans -0.30%
Shs Float 20.04M
Perf Month 1.37%
Income -165.95M
PEG -
EPS next Q -0.30
Inst Own 48.58%
Short Float 3.12%
Perf Quarter -12.78%
Sales 287.53M
P/S 2.23
EPS this Y -151.77%
Inst Trans 1.30%
Short Ratio 2.87
Perf Half Y -9.47%
Book/sh 37.80
P/B 0.57
EPS next Y 9.38%
ROA -12.73%
Short Interest 0.63M
Perf Year -26.70%
Cash/sh 10.26
P/C 2.09
EPS next 5Y -
ROE -13.86%
52W Range 19.88 - 44.09
Perf YTD -25.63%
Dividend Est. -
P/FCF 35.67
EPS past 5Y -78.39%
ROI -14.57%
52W High -51.24%
Beta 1.41
Dividend TTM -
Quick Ratio 5.09
Sales past 5Y 258.65%
Gross Margin 34.74%
52W Low 8.15%
ATR (14) 0.68
Dividend Ex-Date -
Current Ratio 5.09
EPS Y/Y TTM -219.30%
Oper. Margin -26.03%
RSI (14) 55.20
Volatility 4.29% 2.94%
Employees 1184
Debt/Eq 0.01
Sales Y/Y TTM -21.20%
Profit Margin -57.71%
Recom 2.67
Target Price 26.67
Option/Short Yes / Yes
LT Debt/Eq 0.01
EPS Q/Q 12.94%
Payout -
Rel Volume 1.63
Prev Close 21.24
Sales Surprise -1.34%
EPS Surprise 96.86%
Sales Q/Q -2.54%
Earnings May 03 BMO
Avg Volume 217.77K
Price 21.50
SMA20 3.77%
SMA50 -1.68%
SMA200 -20.87%
Trades
Volume 355,657
Change 1.22%
Date
Action
Analyst
Rating Change
Price Target Change
Dec-07-23 Initiated
UBS
Neutral
$35
Dec-08-22 Downgrade
Piper Sandler
Overweight → Neutral
$65 → $40
Nov-18-22 Initiated
Raymond James
Outperform
$45
Aug-25-22 Initiated
Credit Suisse
Outperform
$65
Feb-04-22 Resumed
Piper Sandler
Overweight
$80
Aug-05-21 Resumed
Credit Suisse
Underperform
$55
Jan-08-21 Downgrade
Credit Suisse
Neutral → Underperform
$42 → $40
Nov-24-20 Downgrade
BTIG Research
Buy → Neutral
Aug-20-20 Initiated
Oppenheimer
Outperform
$75
May-29-20 Initiated
BTIG Research
Buy
$20
Nov-05-19 Upgrade
Piper Jaffray
Neutral → Overweight
Mar-01-18 Downgrade
Piper Jaffray
Overweight → Neutral
Nov-07-17 Downgrade
Raymond James
Outperform → Mkt Perform
Show Previous Ratings
Today 09:15AM
03:04AM
May-03-24 10:46PM
(Thomson Reuters StreetEvents)
11:53AM
08:34AM
08:15AM
Loading…
08:15AM
07:00AM
Apr-11-24 04:05PM
Feb-29-24 09:31AM
Feb-28-24 10:18PM
(Thomson Reuters StreetEvents) -8.14%
07:35AM
07:00AM
Feb-13-24 08:00AM
Feb-09-24 08:31AM
Nov-25-23 09:45AM
04:30PM
Loading…
Nov-14-23 04:30PM
Nov-05-23 09:02AM
Nov-03-23 10:26PM
(Thomson Reuters StreetEvents) +13.24%
04:05PM
08:52AM
08:45AM
07:00AM
Oct-30-23 03:46PM
Oct-25-23 08:00AM
Oct-18-23 09:44AM
Oct-17-23 08:00AM
Aug-05-23 08:56AM
Aug-04-23 10:08PM
(Thomson Reuters StreetEvents)
08:15AM
07:00AM
04:05PM
Loading…
Jul-24-23 04:05PM
Jul-18-23 08:00AM
Jun-21-23 08:00PM
Jun-14-23 11:40AM
Jun-06-23 07:45AM
Jun-05-23 08:30AM
May-23-23 09:53AM
08:20AM
May-18-23 04:05PM
May-08-23 11:15AM
09:40AM
May-05-23 08:15AM
07:00AM
Apr-26-23 08:00PM
Apr-20-23 04:05PM
Apr-16-23 02:01PM
Apr-14-23 07:13AM
06:49AM
Apr-12-23 09:40AM
Apr-11-23 08:00AM
Mar-27-23 09:40AM
Mar-24-23 03:54PM
Mar-09-23 09:40AM
Mar-04-23 07:50AM
Mar-03-23 11:17AM
Mar-01-23 10:13AM
(Thomson Reuters StreetEvents)
Feb-28-23 08:25PM
04:05PM
04:03PM
Feb-26-23 09:05AM
Feb-23-23 04:05PM
Feb-14-23 04:05PM
Feb-03-23 05:18AM
Jan-03-23 04:05PM
Dec-15-22 08:11AM
Dec-02-22 12:08PM
Nov-24-22 10:30AM
Nov-17-22 04:05PM
Nov-16-22 06:52AM
Nov-09-22 08:02AM
Nov-07-22 05:55PM
04:06PM
04:05PM
Oct-26-22 07:54AM
Oct-25-22 04:03PM
Oct-20-22 04:03PM
Oct-10-22 11:31AM
Aug-26-22 07:22AM
Aug-25-22 12:10PM
Aug-23-22 02:03PM
Aug-06-22 05:00AM
Aug-05-22 06:30AM
Aug-04-22 07:25PM
04:05PM
08:00AM
08:00AM
Jul-25-22 06:15PM
Jul-19-22 08:00AM
Jul-14-22 06:17PM
Jul-11-22 09:46AM
Jul-05-22 08:00AM
Jun-29-22 06:15PM
Jun-21-22 06:15PM
Jun-19-22 09:06AM
Jun-04-22 08:06AM
May-19-22 07:04AM
May-17-22 11:30AM
May-03-22 11:30PM
05:25PM
04:05PM
Fulgent Genetics, Inc. is a technology company, which engages in the provision of gene testing and sequencing solutions. It offers genes and panels, known mutation, hereditary cancer, carrier screening, and tumor profiling solutions. The company was founded by Ming Hsieh on May 13, 2016 and is headquartered in El Monte, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Xie Jian President and COO Dec 11 '23 Sale 26.52 22,000 583,453 363,124 Dec 13 08:49 PM Xie Jian President and COO Dec 04 '23 Sale 27.57 1,779 49,053 385,124 Dec 06 06:00 PM Gao Hanlin Chief Scientific Officer Dec 04 '23 Sale 27.57 1,437 39,623 905,882 Dec 06 05:47 PM Kim Paul CFO and Treasurer Dec 04 '23 Sale 27.57 1,437 39,623 200,460 Dec 06 05:54 PM Xie Jian President and COO Nov 16 '23 Sale 27.25 1,617 44,065 386,903 Nov 20 04:30 PM Kim Paul CFO and Treasurer Nov 16 '23 Sale 27.25 1,307 35,617 201,897 Nov 20 04:27 PM Xie Jian President and COO Sep 07 '23 Sale 31.41 1,492 46,861 416,022 Sep 11 04:37 PM Kim Paul CFO and Treasurer Sep 07 '23 Sale 31.41 1,492 46,861 214,061 Sep 11 04:35 PM Gao Hanlin Chief Scientific Officer Sep 07 '23 Sale 31.41 1,041 32,696 912,932 Sep 11 04:34 PM Kim Paul CFO and Treasurer Aug 28 '23 Sale 33.62 10,299 346,297 215,553 Aug 30 04:54 PM Kim Paul CFO and Treasurer Aug 17 '23 Sale 33.88 1,798 60,918 225,852 Aug 21 04:40 PM Xie Jian President and COO Aug 17 '23 Sale 33.88 1,307 44,283 417,514 Aug 21 04:43 PM Gao Hanlin Chief Scientific Officer Aug 17 '23 Sale 33.88 342 11,587 913,973 Aug 21 04:34 PM Xie Jian President and COO Jun 02 '23 Sale 40.30 1,433 57,744 425,794 Jun 06 05:11 PM Kim Paul CFO and Treasurer Jun 02 '23 Sale 40.30 1,403 56,535 228,890 Jun 06 05:09 PM Gao Hanlin Chief Scientific Officer Jun 02 '23 Sale 40.30 1,000 40,296 914,391 Jun 06 05:06 PM Xie Jian President and COO May 17 '23 Sale 35.46 1,320 46,810 427,227 May 19 04:23 PM Kim Paul CFO and Treasurer May 17 '23 Sale 35.46 1,266 44,895 230,293 May 19 04:19 PM Gao Hanlin Chief Scientific Officer May 17 '23 Sale 35.46 345 12,234 915,391 May 19 04:15 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite